Health Care: Drugs

Alnylam Pharmaceuticals Inc. (ALNY: NASDAQ)

$53.86 -0.75 | -1.37%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 54.61
52 Week High 112.57
52 Week Low 22.54
Avg. Daily Vol. (Mil) 0.77
Beta (3 year) 2.21
Share Related Items
Mkt Cap (Mil) 3,490.50
Shares Out (Mil) 63.92
Float (Mil) 53.59
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.60
Current Ratio 4.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 74.00
Price/Book 12.91
Price/Cash Flow -44.20
Per Share Data
Earnings -1.45
Sales 0.74
Book Value 4.23
Cash Flow -1.24
Business Summary
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
General Information
300 Third Street
Cambridge, MA 02142
www.alnylam.com
Industry : Drugs
Sector: Health Care
Employees: 165
CEO: Dr. John M. Maraganore,P
Short Interest
Current Month (Mil) 3.56
Previous Month (Mil) 3.52
Short Interest Ratio (Days) 4.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -21.20
Return on Investments -33.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ALNY

Latest ALNY Headlines from TheStreet

More Financial News for ALNY

Press Releases for ALNY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter